AvKARE 2025-10-15 Health serious FDA
Health · FDA · Recall #FDA-D-0007-2026
Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and… Recall
Issued October 15, 2025 · AvKARE
In October 2025, AvKARE recalled the Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Content Uniformity Specifications
What you should do
- 1 Stop using Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact AvKARE to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- AvKARE
- Category
- Health
- Recall date
- October 15, 2025
- Units affected
- Not reported
- Sold at
- U.S. Nationwide
- Recall number
- FDA-D-0007-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- AvKARE has 10 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.